Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology

The treatment landscape for multiple myeloma (MM) is evolving rapidly and includes several new options. The management must be tailored to the individual. The NCCN Guidelines for MM provide a framework to base decisions regarding diagnosis, workup, treatment, and follow-up of both newly diagnosed and previously treated relapsed/refractory MM. This manuscript outlines the recommendations from NCCN Guidelines for MM specific to newly diagnosed MM (NDMM).

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2026-01-01
DOI
https://doi.org/10.6004/jnccn.2026.0001
Citations
1
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
35.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology

Rashmi Kumar, Hans Chulhee Lee, Christopher R. D’Angelo, Srinivas S. Devarakonda et al.
1 citations
Journal of the National Comprehensive Cancer Network
Multiple Myeloma Research and Treatments
35.41
article

Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology

Rashmi Kumar, Hans Chulhee Lee, Christopher R. D’Angelo, Srinivas S. Devarakonda, James Omel, Malin L. Hultcrantz, Kelly Godby, Myo Htut, Erica Campagnaro, D. T. Vogl, Natalie S. Callander, Muhamed Baljević, Amandeep Godara, Noura Elsedawy, Benjamin Avi Derman, Larry Anderson, C. L. Costello, Shayna Sarosiek, J Hillengass, Jason Valent, Kehinde Adekola, Michaela Liedtke, Asya Varshavsky‐Yanovsky, Mark A. Schroeder, Yubin Kang, J Christine Ye, Carol Ann Huff, Leona Holmberg, Emily Kovach, Rachid Baz, Attaya Suvannasankha, Shaji K. Kumar, Aaron Rosenberg, Timothy J. Robinson, Sarah Larson, Daniel Sherbenou, Thomas Martin
article en
1 citations

Abstract

The treatment landscape for multiple myeloma (MM) is evolving rapidly and includes several new options. The management must be tailored to the individual. The NCCN Guidelines for MM provide a framework to base decisions regarding diagnosis, workup, treatment, and follow-up of both newly diagnosed and previously treated relapsed/refractory MM. This manuscript outlines the recommendations from NCCN Guidelines for MM specific to newly diagnosed MM (NDMM).

Journal of the National Comprehensive Cancer NetworkVol. 24(1)
Fox Chase Cancer Center (US), Roswell Park Comprehensive Cancer Center (US), Barnes-Jewish Hospital (US), City Of Hope National Medical Center (US), St. Jude Children's Research Hospital (US), Cleveland Clinic (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), University of Tennessee Health Science Center (US), Breast Cancer Research Foundation (US), University of Utah (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), UC San Diego Health System (US), Huntsman Cancer Institute (US), Cancer Institute (WIA) (IN), Susan Thompson Buffett Foundation (US), WinnMed (US), Yale Cancer Center (US), Moffitt Cancer Center (US), Fred Hutch Cancer Center (US), Southwestern Medical Center (US), Jewish Hospital (US), University of Wisconsin Carbone Cancer Center (US), Sidney Kimmel Cancer Center (US), University Hospitals Seidman Cancer Center (US), Duke Medical Center (US), University of Colorado Cancer Center (US), Patient Advocate Foundation (US), Dana-Farber Brigham Cancer Center (US), Smilow Cancer Hospital (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Moores Cancer Center, University of Chicago Medicine Comprehensive Cancer Center, UCLA Jonsson Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, Stanford Cancer Institute, Duke Cancer Institute, Fred and Pamela Buffett Cancer Center, UC Davis Comprehensive Cancer Center, Harold C. Simmons Comprehensive Cancer Center, O'Neal Comprehensive Cancer Center, National Comprehensive Cancer Network, Indiana University (US), University of Pennsylvania (US), University of California, Davis (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)
Good health and well-being
Openalex Percentile: Top 2%
Multiple Myeloma Research and Treatments
35.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.